Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M J P, Welters"'
Autor:
S. J. Santegoets, C. L. Duurland, E. S. Jordanova, J. J. van Ham, I. Ehsan, S. L. van Egmond, M. J. P. Welters, S. H. van der Burg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Regulatory T cells (Tregs) may comprise different subsets allowing them to efficiently suppress different types of effector T cells. In this study, we show that high numbers of both conventional and Tbet co-expressing Foxp3hi Tregs accumulat
Externí odkaz:
https://doaj.org/article/62868b7ab4e84d2c8edcadb20c09e374
Autor:
S. J. A. M. Santegoets, A. F. de Groot, E. M. Dijkgraaf, A. M. Carnaz Simões, V. E. van der Noord, J. J. van Ham, M. J. P. Welters, J. R. Kroep, S. H. van der Burg
Publikováno v:
OncoImmunology, Vol 7, Iss 8 (2018)
Epithelial ovarian cancer (EOC) may cause abnormal blood levels of leukocytes. This paraneoplastic manifestation is associated with a worse response to therapy and shorter survival. To understand the complexity and nature of these leukocytes, we diss
Externí odkaz:
https://doaj.org/article/f4b6784697f04c0297d742904ad36aca
Autor:
H. van Meir, R. A. Nout, M. J. P. Welters, N. M. Loof, M. L. de Kam, J. J. van Ham, S. Samuels, G. G. Kenter, A. F. Cohen, C. J. M. Melief, J. Burggraaf, M. I. E. van Poelgeest, S. H. van der Burg
Publikováno v:
OncoImmunology, Vol 6, Iss 2 (2017)
New treatments based on combinations of standard therapeutic modalities and immunotherapy are of potential use, but require a profound understanding of immune modulatory properties of standard therapies. Here, the impact of standard (chemo)radiothera
Externí odkaz:
https://doaj.org/article/9ab1477d33ed4379aebc6f6b01ce1a4c
Autor:
H, Van Meir, I J, du Burck, M L, de Kam, M J P, Welters, S H, van der Burg, J B M Z, Trimbos, C D, de Kroon, M I E, van Poelgeest
Publikováno v:
European journal of gynaecological oncology. 38(1)
To investigate prognostic factors in patients with recurrent cervical cancer after treatment of early-stage disease in order to identify high-risk patients who might benefit from alternative treatment strategies.The authors retrospectively analyzed c
Autor:
L. M. B. Vaessen, W. Weimar, Alexander P.A. Stegmann, F. B. S. Oei, M. J. P. Welters, Ad J.J.C. Bogers
Publikováno v:
Clinical & Experimental Immunology, 124, 353-358. Wiley-Blackwell Publishing Ltd
SUMMARY Implantation of cryopreserved human donor heart valves for either congenital or acquired cardiac disease has been performed since the last three decades. Although the clinical outcome is good, long-term valve degeneration resulting in dysfunc
Autor:
R.J. Scheper, R.A. Baan, M.J. Flens, A.M.J. Fichtinger-Schepman, Boudewijn J.M. Braakhuis, M. J. P. Welters
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 4, 77, 556-561
British Journal of Cancer, 4, 77, 556-561
Resistance to chemotherapy is a major problem in the treatment of patients with head and neck squamous cell carcinoma (HNSCC). Important factors involved are drug detoxification by glutathione (GSH) and reduced drug accumulation due to active transpo
Autor:
Boudewijn J.M. Braakhuis, A. J. Jacobs-Bergmans, W.J.F. van der Vijgh, Robert A. Baan, A.M.J. Fichtinger-Schepman, M. J. P. Welters, A Kegel
Publikováno v:
Annals of Oncology, 10, 97-103. Oxford University Press
Annals of Oncology, 1, 10, 97-103
Welters, M J P, Braakhuis, B J M, Jacobs-Bergmans, A J, Kegel, A, Baan, R A, van der Vijgh, W J F & Fichtinger-Schepman, A M J 1999, ' The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy ', Annals of Oncology, vol. 10, pp. 97-103 . https://doi.org/10.1023/A:1008324803494
Annals of Oncology, 10, 97-103
Annals of Oncology, 1, 10, 97-103
Welters, M J P, Braakhuis, B J M, Jacobs-Bergmans, A J, Kegel, A, Baan, R A, van der Vijgh, W J F & Fichtinger-Schepman, A M J 1999, ' The potential of platinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapy ', Annals of Oncology, vol. 10, pp. 97-103 . https://doi.org/10.1023/A:1008324803494
Annals of Oncology, 10, 97-103
Background: Response to cisplatin-therapy is assumed to be related to the formation of platinum (Pt)-DNA adducts. Measurement of these adducts prior to therapy could be of value to improve cisplatin based cancer therapy. Materials and methods: We det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54cbd00414ce78c512a069002ac1173c
https://research.vumc.nl/en/publications/8afaa686-92a2-49b4-83e0-022a5e4a2e57
https://research.vumc.nl/en/publications/8afaa686-92a2-49b4-83e0-022a5e4a2e57
Autor:
A.M.J. Fichtinger-Schepman, Boudewijn J.M. Braakhuis, A Kegel, M. J. P. Welters, A. J. Jacobs-Bergmans, W.J.F. van der Vijgh, Robert A. Baan
Publikováno v:
Welters, M J P, Fichtinger-Schepman, A M J, Baan, R A, Jacobs-Bergmans, A J, Kegel, A, van der Vijgh, W J F & Braakhuis, B J M 1999, ' Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo ', British Journal of Cancer, vol. 79, pp. 82-88 . https://doi.org/10.1038/sj.bjc.6690015
British Journal of Cancer, 79, 82-88. Nature Publishing Group
British Journal of Cancer, 1, 79, 82-88
British Journal of Cancer
British Journal of Cancer, 79, 82-88. Nature Publishing Group
British Journal of Cancer, 1, 79, 82-88
British Journal of Cancer
Total platinum contents and cisplatin–DNA adduct levels were determined in vivo in xenografted tumour tissues in mice and in vitro in cultured tumour cells of head and neck squamous cell carcinoma (HNSCC), and correlated with sensitivity to cisplat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f87e8ea895dd180ee4a995deac35c70
https://research.vumc.nl/en/publications/4d75c7cc-1ec2-4647-983c-7b2b1ef896bb
https://research.vumc.nl/en/publications/4d75c7cc-1ec2-4647-983c-7b2b1ef896bb
Autor:
Boudewijn J.M. Braakhuis, M. J. P. Welters, Robert A. Baan, A. J. Jacobs-Bergmans, A.M.J. Fichtinger-Schepman, J. Ma, M. Maliepaard, Jan H.M. Schellens, W. J. F. Van Der Vijgh
Publikováno v:
Welters, M J P, Maliepaard, M, Jacobs-Bergmans, A J, Baan, R A, Schellens, J H M, Ma, J G, van der Vijgh, W J F & Braakhuis, B J M 1997, ' Improved P-32 postlabelling assay for teh quantification of the major platinum-DNA adducts ', Carcinogenesis, vol. 18, pp. 1767-1774 . https://doi.org/10.1093/carcin/18.9.1767
Carcinogenesis, 18, 1767-1774. Oxford University Press
Carcinogenesis, 18, 1767-1774. Oxford University Press
For the improvement of chemotherapy with platinum (Pt)-containing drugs a sensitive assay to detect the induced Pt-DNA adducts is needed. Therefore, the 32P-postlabelling assay, described by Blommaert and Saris (Nucleic Acids Res., 1995, 23, 1300-130
Autor:
Robert A. Baan, Mario A. J. A. Hermsen, Jacqueline Cloos, M. J. P. Welters, Wim J.F. van der Vijgh, A.M.J. Fichtinger-Schepman, Boudewijn J.M. Braakhuis
Publikováno v:
International Journal of Cancer, 71(3), 410-415. Wiley-Liss Inc.
Welters, M J P, Fichtinger-Schepman, A M J, Baan, R A, Hermsen, M A J A, Van Der Vijgh, W J F, Cloos, J & Braakhuis, B J M 1997, ' Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines ', International Journal of Cancer, vol. 71, no. 3, pp. 410-415 . https://doi.org/10.1002/(SICI)1097-0215(19970502)71:3<410::AID-IJC18>3.0.CO;2-J
Welters, M J P, Fichtinger-Schepman, A M J, Baan, R A, Hermsen, M A J A, Van Der Vijgh, W J F, Cloos, J & Braakhuis, B J M 1997, ' Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines ', International Journal of Cancer, vol. 71, no. 3, pp. 410-415 . https://doi.org/10.1002/(SICI)1097-0215(19970502)71:3<410::AID-IJC18>3.0.CO;2-J
Patients with head and neck squamous cell carcinoma (HNSCC) treated with cisplatin show a large inter-individual variation in tumor response. Little is known about factors that contribute to this variation. The aim of our study was to correlate the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451133cb90416ced8343243c27f3aca7
https://research.vumc.nl/en/publications/7a2efd1c-a327-492c-ae79-065b6e1c1281
https://research.vumc.nl/en/publications/7a2efd1c-a327-492c-ae79-065b6e1c1281